Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) Price Target at $29.11

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have been assigned a consensus rating of “Buy” from the nine brokerages that are currently covering the stock, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $29.11.

Several research analysts recently weighed in on ASPN shares. HC Wainwright reaffirmed a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Roth Mkm cut their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. Barclays lowered their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. Piper Sandler dropped their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Canaccord Genuity Group reduced their target price on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, January 16th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Lord Abbett & CO. LLC acquired a new stake in Aspen Aerogels in the third quarter valued at approximately $10,126,000. Oppenheimer & Co. Inc. lifted its stake in shares of Aspen Aerogels by 167.2% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock valued at $2,839,000 after purchasing an additional 64,154 shares during the last quarter. Sanders Morris Harris LLC lifted its stake in shares of Aspen Aerogels by 337.5% in the 4th quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after purchasing an additional 27,000 shares during the last quarter. Penserra Capital Management LLC bought a new stake in Aspen Aerogels in the third quarter worth $1,342,000. Finally, Geode Capital Management LLC increased its position in Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after buying an additional 75,024 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Trading Down 2.7 %

Aspen Aerogels stock opened at $11.33 on Monday. The stock has a market capitalization of $929.79 million, a PE ratio of 1,134.33 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a 12-month low of $10.75 and a 12-month high of $33.15. The firm has a 50 day simple moving average of $13.30 and a 200-day simple moving average of $20.02.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.